ArticleCureus2024
Efficacy of Platelet-Rich Plasma (PRP) in Treating Plantar Fasciitis.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Brief Overview and Update of Regenerative Medicine for the Treatment of Musculoskeletal Conditions.Current reviews in musculoskeletal medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlatelet-rich plasma (PRP) is an autologous blood derivative with an enhanced platelet concentration and can enhance the tissue-healing process naturally. Plasma with a higher concentration of platelets on activation leads to the release of various growth factors that in turn augment tissue repair and jump-start the healing process. The aim of this study was to determine the efficacy of PRP in reducing pain and improving functional outcomes in patients with plantar fasciitis who had failed to respond to conservative treatment.
methodsA retrospective study was performed at the Orthopedics Department of the Ghurki Trust Teaching Hospital, Lahore, during March 2020 to January 2021. A total of 140 patients, 25 to 65 years of age, with plantar fasciitis were included. Patients who had undergone foot surgery in the past, those with a generalized inflammatory disorder, pregnant female patients, those taking anticoagulants and those with tumours of the lower extremity were excluded. Following aseptic measures, 2.5 ml of PRP containing 5.5% calcium chloride was administered at the most tender point on the medial aspect of the heel. All injections were administered by the principal researcher himself. All patients were followed at regular intervals post-therapy and efficacy was measured at the end of three months post-therapy.
resultsThe average age of participants was 41.56 ± 10.37 years, with most patients (94 out of 140, 67.14%) falling in the 25-45 age range. The study population consisted of 89 male (63.57%) and 51 female (36.43%) patients, with a male-to-female ratio of 1.7:1. PRP therapy was effective in 131 patients (93.57%), and age was found to be a significant factor influencing treatment success (p < 0.05).
conclusionPRP is a highly effective treatment option for plantar fasciitis, providing substantial symptomatic relief and improving patient outcomes, specially in patients unresponsive to conservative treatment. Further research is necessary to confirm these results and establish standardized guidelines for its use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.